Related Experiment Video
Updated: Jun 10, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase
Marina Zemskova1, Michael B Lilly, Ying-Wei Lin
1Department of Cell and Molecular Pharmacology, Hollings Cancer Center, Charleston, SC 29425, USA.
Abstract:
The PIM family of serine threonine protein kinases plays an important role in regulating both the growth and transformation of malignant cells. However, in a cell line-dependent manner, overexpression of PIM1 can inhibit cell and tumor growth. In 22Rv1 human prostate cells, but not in Du145 or RWPE-2, PIM1 overexpression was associated with marked increases in cellular senescence, as shown by changes in the levels of beta-galactosidase (SA-beta-Gal), p21, interleukin (IL)-6 and IL-8 mRNA and protein. During early cell passages, PIM1 induced cellular polyploidy. As the passage number increased, markers of DNA damage, including the level of gammaH2AX and CHK2 phosphorylation, were seen. Coincident with these DNA damage markers, the level of p53 protein and genes transcriptionally activated by p53, such as p21, TP53INP1, and DDIT4, increased. In these 22Rv1 cells, the induction of p53 protein was associated not only with senescence but also with a significant level of apoptosis. The importance of the p53 pathway to PIM1-driven cellular senescence was further shown by the observation that expression of dominant-negative p53 or shRNA targeting p21 blocked the PIM1-induced changes in the DNA damage response and increases in SA-beta-Gal activity. Likewise, in a subcutaneous tumor model, PIM1-induced senescence was rescued when the p53-p21 pathways are inactivated. Based on these results, PIM1 will have its most profound effects on tumorigenesis in situations where the senescence response is inactivated.
Insights
Overexpression of PIM1 kinase induces cellular senescence and DNA damage in prostate cancer cells, primarily through the p53 pathway. This senescence can inhibit tumor growth when the p53-p21 pathway is active.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The PIM family of serine/threonine protein kinases regulates malignant cell growth and transformation.
- PIM1 overexpression can inhibit cell and tumor growth in a cell-dependent manner.
Purpose of the Study:
- To investigate the role of PIM1 overexpression in cellular senescence and its underlying mechanisms in human prostate cancer cells.
- To determine the impact of PIM1 on DNA damage response and apoptosis pathways.
Main Methods:
- Overexpression of PIM1 in 22Rv1, Du145, and RWPE-2 human prostate cells.
- Assessment of senescence markers (SA-beta-Gal, p21, IL-6, IL-8).
- Analysis of DNA damage markers (gammaH2AX, CHK2 phosphorylation) and p53 pathway activation.
- In vivo studies using a subcutaneous tumor model.
Main Results:
- PIM1 overexpression induced senescence, polyploidy, and DNA damage in 22Rv1 cells, but not in Du145 or RWPE-2 cells.
- The p53 pathway, including p53 protein and downstream targets like p21, was activated by PIM1, leading to senescence and apoptosis.
- Inactivation of the p53-p21 pathway abrogated PIM1-induced senescence in vitro and in vivo.
Conclusions:
- PIM1-induced senescence in prostate cancer cells is dependent on the p53-p21 pathway.
- PIM1's effect on tumorigenesis is most significant when the senescence response is compromised.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity
